Stockreport

Genmab A/S (GNMSF) CEO Jan van de Winkel on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha]

GENMAB A/S  (GMXAY) 
NASDAQ:AMEX Investor Relations: ir.genmab.com
PDF Genmab A/S (GNMSF) CEO Jan van de Winkel on Q1 2019 Results - Earnings Call Transcript Genmab A/S ( OTCPK:GNMSF Company Participants Jan van de Winkel - Co-Founder, CEO [Read more]